相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota
Li Cui et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment
Xiao Yan Guo et al.
JOURNAL OF DIGESTIVE DISEASES (2020)
Lizhong decoction ameliorates ulcerative colitis in mice via modulating gut microbiota and its metabolites
Junfeng Zou et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies
Amandip Kaur et al.
JOURNAL OF INFLAMMATION-LONDON (2020)
Indigo Naturalis Alleviates Dextran Sulfate Sodium-Induced Colitis in Rats via Altering Gut Microbiota
Zhongmei Sun et al.
FRONTIERS IN MICROBIOLOGY (2020)
6-gingerol alleviates inflammatory injury in DSS-induced ulcerative colitis mice by regulating NF-κB signaling
Yingyue Sheng et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
Huai hua san alleviates dextran sulphate sodium-induced colitis and modulates colonic microbiota
Ping Liu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Treatment with Luteolin Improves Lipopolysaccharide-Induced Periodontal Diseases in Rats
Giovanna Casili et al.
BIOMEDICINES (2020)
Luteolin ameliorates experimental colitis in mice through ERK-mediated suppression of inflammation, apoptosis and autophagy
Iva Vukelic et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
Gallic acid improved inflammation via NF-κB pathway in TNBS-induced ulcerative colitis
Lei Zhu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Gut microbiota modulation and anti-inflammatory properties of anthocyanins from the fruits of Lycium ruthenicum Murray in dextran sodium sulfate-induced colitis in mice
Yujia Peng et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
A unique polysaccharide from Hericium erinaceus mycelium ameliorates acetic acid-induced ulcerative colitis rats by modulating the composition of the gut microbiota, short chain fatty acids levels and GPR41/43 respectors
Shuai Shao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases
Kuebra Bunte et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Resolution of ulcerative colitis
Markus F. Neurath et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Aesculin protects against DSS-Induced colitis though activating PPARγ and inhibiting NF-κB pathway
Xinlei Tiana et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Honey Polyphenols Ameliorate DSS-Induced Ulcerative Colitis via Modulating Gut Microbiota in Rats
Haoan Zhao et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2019)
Anti-Inflammatory Activity of a Peptide from Skipjack (Katsuwonus pelamis)
Zhi-gao Wang et al.
MARINE DRUGS (2019)
Luteolin Attenuates Atherosclerosis Via Modulating Signal Transducer And Activator Of Transcription 3-Mediated Inflammatory Response
Xiaoji Ding et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
The role of gut microbiota in intestinal and liver diseases
Tomas Hrncir et al.
LABORATORY ANIMALS (2019)
Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses
Li Li et al.
PHYTOMEDICINE (2019)
Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota
Minna Wu et al.
PHARMACOLOGICAL RESEARCH (2019)
A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease
Pedro Goncalves et al.
INFLAMMATORY BOWEL DISEASES (2018)
Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies
Nur Aziz et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Insights into Roseburia intestinalis which alleviates experimental colitis pathology by inducing anti-inflammatory responses
Zhaohua Shen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Salvianolic acid B alters the gut microbiota and mitigates colitis severity and associated inflammation
Xinyue Wu et al.
JOURNAL OF FUNCTIONAL FOODS (2018)
Hydrogen peroxide production by lactobacilli promotes epithelial restitution during colitis
Ashish K. Singh et al.
REDOX BIOLOGY (2018)
Precision editing of the gut microbiota ameliorates colitis
Wenhan Zhu et al.
NATURE (2018)
Protective Mechanisms of Butyrate on Inflammatory Bowel Disease
Joao P. B. Silva et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Reduced Mucosa-associated Butyricicoccus Activity in Patients with Ulcerative Colitis Correlates with Aberrant Claudin-1 Expression
Sarah Devriese et al.
JOURNAL OF CROHNS & COLITIS (2017)
Administration of geniposide ameliorates dextran sulfate sodium-induced colitis in mice via inhibition of inflammation and mucosal damage
Zecai Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
The IBD interactome: an integrated view of aetiology, pathogenesis and therapy
Heitor S. P. de Souza et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
miR-155 targets Est-1 and induces ulcerative colitis via the IL-23/17/6-mediated Th17 pathway
Jiangtao Hou et al.
PATHOLOGY RESEARCH AND PRACTICE (2017)
Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice
Lien Van den Bossche et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2017)
Involvement of PPAR in the protective action of tropisetron in an experimental model of ulcerative colitis
Reza Rahimian et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2016)
Luteolin ameliorates dextran sulfate sodium-induced colitis in mice possibly through activation of the Nrf2 signaling pathway
Yue Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies
Eleonora Distrutti et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Quantitative Analysis of Intestinal Flora of Uygur and Han Ethnic Chinese Patients with Ulcerative Colitis
Ping Yao et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis
Kathleen Machiels et al.
GUT (2014)
Role of Intestinal Bacteria in the Pathogenesis of Pouchitis
Daisy Batista et al.
INFLAMMATORY BOWEL DISEASES (2014)
Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2
Ashok Kumar Pandurangan et al.
PHARMACOGNOSY MAGAZINE (2014)
Comparative evaluation of different doses of PPAR-γ agonist alone and in combination with sulfasalazine in experimentally induced inflammatory bowel disease in rats
Prasad Byrav D.S. et al.
Pharmacological Reports (2014)
Advances in treatment of ulcerative colitis with herbs: From bench to bedside
Ping Wan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
CD4+ T-cell subsets in intestinal inflammation
Matthew Shale et al.
IMMUNOLOGICAL REVIEWS (2013)
Host-Gut Microbiota Metabolic Interactions
Jeremy K. Nicholson et al.
SCIENCE (2012)
The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon
Dallas R. Donohoe et al.
CELL METABOLISM (2011)
Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis
Akira Andoh et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Disease Characteristics of Inflammatory Bowel Disease (IBD) Findings from a Tertiary Care Centre in South Asia
Duminda Subasinghe et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
Luteolin suppresses inflammation-associated gene expression by blocking NF-κB and AP-1 activation pathway in mouse alveolar macrophages
Chiu-Yuan Chen et al.
LIFE SCIENCES (2007)
A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis
H. Ogata et al.
GUT (2006)
Therapeutic effect of intracolonically administered nuclear factor κB (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis
M Murano et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)